Klinische Forschung Schwerin GmbH
- Address
- Friedrichstrasse 1, Altstadt, 19055 Schwerin, Germany
Nutritional and Metabolic Diseases
At Klinische Forschung Schwerin GmbH, clinical research focuses on nutritional and metabolic diseases, with obesity as the main condition being studied. The trials are designed to assess whether a new therapy can improve weight-related health outcomes and support better disease management.
- Studies in obesity and related weight disorders
- Evaluation of a potential treatment for reducing body weight
- Assessment of effects on HbA1c and overall metabolic control
These trials aim to compare an investigational treatment with placebo to understand its effectiveness in people living with obesity, including those with diabetes and those with weight-related comorbidities.
Obesity and Weight-Related Health Research
This research site in Schwerin is also involved in studies centered on obesity management, exploring whether a new approach can lead to meaningful reductions in body weight. The work is relevant for people with overweight or obesity who may also have other health concerns.
- Clinical trials in overweight and obesity
- Investigation of treatment benefit in participants with and without diabetes
- Focus on improving weight outcomes and related metabolic measures
The overall purpose is to evaluate treatment effectiveness and safety, helping clarify whether the therapy may offer a useful option for managing excess weight and associated conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 10 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1AstraZeneca AB2active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eli Lilly & Co.3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinische Forschung Schwerin GmbH
lock Showing 1 of 17 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial | Eli Lilly & Co. | Phase III | Not Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 19 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| HRS 9531 | 2 | Unknown | 2026-06-16 | 2026-06-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.